Evaluation of pre-exposure vaccine effectiveness against mpox during the 2022–2023 mpox outbreak in the Madrid region (Spain): a test-negative design
Introduction An appropriate vaccination approach is critical to control the current outbreak of mpox but there is little research providing information on its effectiveness, particularly under circumstances of limited vaccine availability.Methods Pre-exposure vaccination campaign in the Madrid regio...
Saved in:
Main Authors: | José Francisco Barbas del Buey, Jesús Íñigo Martínez, Marcos Alonso García, Andrés Aragón Peña, Laura Montero Morales, Araceli Arce Arnáez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-04-01
|
Series: | BMJ Public Health |
Online Access: | https://bmjpublichealth.bmj.com/content/2/1/e000620.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mpox clade I outbreak: how should Asia prepare and respond?
by: Poh Lian Lim, et al.
Published: (2024-09-01) -
Serum Mpox-specific IgG titers before and after breakthrough Mpox infection in an HIV-infected individual with viral suppression and prior 2-dose Mpox vaccination
by: Wang-Da Liu, et al.
Published: (2025-02-01) -
A new STI in the city: MPOX in Barcelona. First outbreak (5/2022-5/2023) and subsequent resurgence.
by: David Palma, et al.
Published: (2025-01-01) -
Decoding mpox: a systematic review and meta-analysis of the transmission and severity parameters of the 2022–2023 global outbreak
by: Adriana Buitrago-Lopez, et al.
Published: (2025-01-01) -
A new STI in the city: MPOX in Barcelona. First outbreak (5/2022-5/2023) and subsequent resurgence
by: David Palma, et al.
Published: (2025-01-01)